Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, clinical medicine and surgery, public health, technology and engineering, law, environmental policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences.
Driven by her visionary passion and ceaseless curiosity, Mary Ann Liebert identifies and nurtures critical topics and cutting-edge fields by creating first-to-market, specialized publications that play a vital role in advancing research and facilitating collaboration in academia, industry, and government. The company is deeply committed to ensuring the highest quality content and is able to invest for the long-term, supporting publications in emerging markets through to maturity.
The company’s flagship publication, Genetic Engineering & Biotechnology News (GEN), was launched in 1980, the very first publication of its kind for the field of biotechnology. Today, GEN is the most widely read and highly regarded publication in the field, delivering cutting-edge news and analysis of the technologies, applications, and trends that are driving the future of biotechnology. GEN has been at the forefront of the field since the birth of biotech, maintaining unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
The company has published many “firsts” in the market, including AIDS Research and Human Retroviruses, Human Gene Therapy, LGBT Health, and, most recently, The CRISPR Journal.
Mary Ann Liebert, Inc. provides fast and flexible models for authors, libraries, and institutions that enable rapid dissemination and high visibility of published content. The company’s mission is to advance research and development, foster collaborations that enable best therapeutic options, and, ultimately, to improve patient care.
140 Huguenot Street
New Rochelle, NY
10801-5215
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 |
| Friday | 09:00 - 17:00 |
Be the first to know and let us send you an email when Mary Ann Liebert, Inc., publishers posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Mary Ann Liebert, Inc., publishers:
Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher with a portfolio of over 90 peer-reviewed journals, leading trade magazines, and newsletters, in addition to society membership management and conferences.
Our publications focus on cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines.
We are, however, more than just a publisher. Mary Ann Liebert, Inc. collaborates effectively with corporations, educational institutions, nonprofit foundations, and is committed to meeting the needs of the members of academia, government, and industry around the world.
Browse our publications, explore the content of our established journals, and learn more about our extensive capabilities here: https://www.liebertpub.com/
As always, Mary Ann and the team welcome your feedback and input. Get in touch: https://home.liebertpub.com/contact-us
